The emergence of injectable medications like semaglutide and tirzepatide has transformed the approach to managing type 2 diabetes and achieving weight reduction. While both drugs share a similar mechanism of action – mimicking the effects of the natural hormone GLP-1 – tirzepatide possesses a novel advantage: it’s a dual agonist, targeting bo… Read More